Sometimes even this simple sounding question can generate an incredible amount of discussion. If we take the question a step further and ask how do you want to represent this molecule then even the best cross-functional team is likely to be divided.
The answers will of course differ depending on your scientific background and the size of the molecule. As you move towards the small molecule end of the spectrum the chemical structure of the molecule in question becomes more and more important and not just to the chemists in your team.
In Bioregister 3.2 we introduced the ability to generate full chemical representations of natural and non-natural entities. This enables scientists to visualise and share the chemical structures of their molecules and query them via sub-structure searches and share structures with collaborators.
With Bioregister 2020.1 we take a further step forward with the introduction of chemical structure uniqueness checking. Where one monomer ends and another begins is not always as obvious as it might sound and, even within an organisation, can be open to interpretation. We recommend that monomers are defined as the smallest chemically divisible unit, however we recognise that this does not always map easily to lab-based workflows. This means that if uniqueness is based on monomer sequence alone, chemically identical molecules can be registered as separate entities. It is vital that your registration system can recognise when two molecules represented by different monomers are actually chemically identical and Bioregister delivers just that.
Such talk of chemical structure leads us to another key development in Bioregister 2020.1: new workflows for the conjugation of biologically active molecules.
The conjugation of two or more biologically active molecules, be that antibody-drug conjugates or short peptides, often via a linker moiety, is a widely used technique. So called ‘click’ chemistry, the cycloaddition of azides and terminal alkynes, is commonly used due to selectivity and high yielding nature of the reaction. When building a molecule from a sequence definition, the monomers are joined together via their attachment points (R-groups) with the concomitant loss of the capping groups: i.e. water is lost in amide or phosphodiester bond forming reactions. In cycloaddition chemistry no capping groups are “lost” because all the atoms of the starting materials are also found in the product (the atoms of the alkyne and azide = the atoms of the triazole). As noted recently by the Pistoia Alliance, this type of chemistry poses challenges when using monomer-based representations of macromolecules such as HELM and that used in Bioregister. Bioregister 2020.1 removes the complexity of mapping this process by providing an automatic cross-linking workflow to enable the generation of click chemistry products which can be used for both single and bulk registration. The out-of-the-box monomers support the generation of 1,4-disubstitured triazoles and are provide a worked example showing how this functionality can be used to support other cycloaddition reactions.
For further information on Bioregister, visit www.dotmatics.com/products/bioregister.
For further information on Chemically-Modified Therapeutics and to view a recorded webinar highlighting the new Bioregister release, please visit: https://www.dotmatics.com/cmt.
To view tutorials on Bioregister 2020.1 capabilities, click here.